- ICH GCP
- US Clinical Trials Registry
- Researchers
- France
- Pancreatic Cancer
Medical specialists from France tagged as investigators in clinical trials studying Pancreatic Cancer
Total 205 results
-
Nicolas WILLIET, MDSeen in:
- Saint-Étienne, Chu Saint-Etienne
Trials:- NCT04374175 (Principal Investigator)
Conditions: -
Nils STEUERSeen in:
- Bobigny, CHU Avicenne
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
Olivia LE SAUX, MDSeen in:
- Pierre-Bénite, Centre Hospitalier Lyon Sud
- Pierre-Bénite, Service d'Oncologie médicale du Centre hospitalier Lyon Sud
Trials:- NCT03787056 (Sub-Investigator)
- NCT03989323 (Sub-Investigator)
-
Olivier Bouché, MD PhDSeen in:
- Reims, CHU de Reims
Trials:- NCT03400072 (Principal Investigator)
Conditions: -
Olivier Riou, MDSeen in:
- Montpellier, Institut régional du Cancer de Montpellier
Trials:- NCT04698915 (Principal Investigator)
-
Pascal ARTRUSeen in:
- Lyon, Clinique Privée Jean Mermoz
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
Pascal HAMMEL, MDSeen in:
- Clichy, Hopital Beaujon
Trials:- NCT02184663 (Principal Investigator)
- NCT03704480 (Principal Investigator)
- NCT02979483 (Principal Investigator)
- NCT03400072 (Principal Investigator)
-
PASCALE TOMASINISeen in:
- Bouches-du-Rhône, Marseille, Assistance Publique Hôpitaux de Marseille - Hôpital de la Timone
- Marseille Cedex 20, Assistance Publique Hôpitaux de Marseille - Hôpital Nord
- Marseille, AP-HM
- Marseille, APHM Hôpital de la Timone
Trials:- NCT04819100 (Principal Investigator)
- NCT03906331 (Principal Investigator)
- NCT03157128 (Principal Investigator)
-
Patrice PEYRATSeen in:
- Rhone-alpes, Lyon, Centre Léon Berard
Trials:- NCT06211933 (Sub-Investigator)
Conditions: -
Patricia Thoreux, MD PhDSeen in:
- Paris, Hôpital Cochin
Trials:- NCT03400072 (Sub-Investigator)
Conditions: -
Patrick DUFOUR, PrSeen in:
- Strasbourg, Centre PAUL STRAUSS
Trials:- NCT02818907 (Principal Investigator)
Conditions: -
Patrick RAT, PrSeen in:
- Dijon, Centre Hospitalier Universitaire De Dijon
Trials:- NCT02818907 (Principal Investigator)
Conditions: -
Philippe BACHELLIER, PrSeen in:
- Strasbourg, CHU de Strasbourg - Hautepierre
Trials:- NCT02818907 (Principal Investigator)
Conditions: -
Philippe CASSIER, MDSeen in:
- Lyon, Centre Berard Leon
- Lyon, Centre Léon Berard
Trials:- NCT02912949 (Principal Investigator)
- NCT04913285 (Principal Investigator)
- NCT05668585 (Principal Investigator)
- NCT05615818 (Principal Investigator)
- NCT05275478 (Principal Investigator)
- NCT05732831 (Principal Investigator)
- NCT05114668 (Principal Investigator)
-
Philippe MERLE, MDSeen in:
- Lyon, Hôpital de la Croix Rousse
- Lyon, Service d'ONCOLOGIE DIGESTIVE et HEPATOLOGIE de l'hôpital de la Croix-Rousse
Trials:- NCT03787056 (Sub-Investigator)
- NCT03989323 (Sub-Investigator)
-
Philippe PAPAREL, MDSeen in:
- Pierre-Bénite, Service d'Urologie de l'hôpital Lyon Sud
Trials:- NCT03787056 (Principal Investigator)
-
Philippe ROCHIGNEUX, MDSeen in:
- Marseille, Institut Paoli Calmettes
Trials:- NCT03915678 (Principal Investigator)
-
Philippe SOYERSeen in:
- Osny, CH Privé Sainte Marie
Trials:- NCT03693677 (Principal Investigator)
Conditions: -
Pierre Adrien BOLZE, MDSeen in:
- Pierre-Bénite, Service de Gynécologie de l'hôpital Lyon Sud
Trials:- NCT03787056 (Principal Investigator)
-
Pierre Emmanuel COLOMBO, MDSeen in:
- Occ, Montpellier, Institut régional du Cancer de Montpellier
Trials:- NCT04136132 (Principal Investigator)
Conditions: -
Pierre MICHELSeen in:
- Rouen, CHU Charles Nicolle
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
Pierre ROMPTEAUXSeen in:
- Bobigny, CHU Avicenne
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
Pierre-Guillaume Poureau, MDSeen in:
- Brest, CHU de Brest
Trials:- NCT03400072 (Sub-Investigator)
Conditions: -
Pierre-Luc ETIENNESeen in:
- Plérin, Centre Cario HPCA
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
Pietro ADDEO, MDSeen in:
- Strasbourg, Service de Chirurgie Générale, Hépatique, Endocrinienne et Transplantation - CHU de Strasbourg - France
Trials:- NCT05528614 (Principal Investigator)
Conditions: -
Roger FAROUX, MDSeen in:
- La Roche Sur Yon, CHD Vendee
- La Roche sur Yon, CHD Vendee
Trials:- NCT02184663 (Principal Investigator)
- NCT01910610 (Principal Investigator)
-
Rolande NGUEFACKSeen in:
- Suresnes, CH Foch
Trials:- NCT03693677 (Sub-Investigator)
Conditions: -
Rosine Guimbaud, MD PhDSeen in:
- Toulouse, CHU de Toulouse
Trials:- NCT03400072 (Principal Investigator)
Conditions: -
Samy LOUAFISeen in:
- Corbeil-Essonnes, CH - Sud Francilien
- Corbeil-Essonnes, CH Sud Francilien
- Longjumeau, CH
Trials:- NCT03693677 (Principal Investigator)
- NCT02885753 (Principal Investigator)
Conditions:
Clinical Trials on Pancreatic Cancer
-
City of Hope Medical CenterRecruitingPancreatic Neoplasms | Pancreatic Cancer | Pancreatic Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Pancreatic Cancer Resectable | Pancreatic Carcinoma | Pancreatic Cancer Non-resectable | Pancreatic Cancer Stage III | Pancreatic Cancer Stage | Pancreatic Cancer Stage II | Pancreatic Cancer, Adult | Pancreatic... and other conditionsKorea, Republic of, United States, Japan
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CelgeneWithdrawnPancreatic Ductal Adenocarcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
University of NebraskaNational Cancer Institute (NCI)CompletedPancreatic Adenocarcinoma | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage II Pancreatic Cancer | Stage I Pancreatic Cancer | Resectable Pancreatic Carcinoma | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedPancreatic Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedPancreatic Adenocarcinoma | Resectable Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer | Poorly Differentiated Malignant Neoplasm | Undifferentiated Pancreatic CarcinomaUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnStage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer
-
National Cancer Institute (NCI)CompletedStage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
University of UtahNovartis PharmaceuticalsRecruitingMetastatic Pancreatic Carcinoma | Unresectable Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage II Pancreatic CancerUnited States
-
Shanghai Zhongshan HospitalFudan UniversityNot yet recruitingPancreatic Cancer Stage III | Pancreatic Cancer, Stage IB | Pancreatic Cancer, Stage IIA | Pancreatic Cancer, Stage IIBChina
-
University of Wisconsin, MadisonCompletedStage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States